As graphene production scales from laboratory quantities to industrial volumes — tonnes per year and growing — the question of occupational safety becomes urgent rather than academic. Workers in graphene production facilities handle powdered nanomaterials daily. Downstream manufacturers incorporate graphene into composites, coatings, and inks. Consumers use products containing graphene additives.
The toxicology of graphene is an active area of research, and the honest assessment is that we know some things, suspect others, and remain genuinely uncertain about much of it. This article summarizes the current state of knowledge, identifies the most significant gaps, and outlines the precautionary approach that the available evidence supports.
Why Graphene Safety Is Complicated
Graphene is not a single material. The graphene family includes monolayer graphene, few-layer graphene, graphene nanoplatelets, graphene oxide, reduced graphene oxide, and functionalized variants of each. These materials differ in size, thickness, surface chemistry, surface charge, and aggregation behavior — all of which influence biological interactions.
A study showing that graphene oxide causes inflammation in cell culture does not necessarily tell you anything about the toxicity of unfunctionalized graphene nanoplatelets inhaled as an aerosol. A study on the effects of few-layer graphene ingested by zebrafish does not predict the occupational health risk of CVD graphene film production. The specific material, the exposure route, the dose, and the duration all matter.
This material diversity makes generalized safety claims — “graphene is safe” or “graphene is toxic” — essentially meaningless. Safety has to be assessed for specific materials, specific exposure scenarios, and specific durations.
Inhalation: The Primary Occupational Concern
For workers in graphene production and handling facilities, inhalation of airborne graphene particles is the primary occupational health concern. This is consistent with the occupational health experience of other nanomaterials and fine particulates.
What animal studies show. Inhalation and intratracheal instillation studies in rodents have demonstrated that graphene-family materials can cause pulmonary inflammation. The severity depends on the specific material: graphene oxide generally provokes a stronger inflammatory response than pristine graphene, likely due to its surface chemistry and hydrophilicity. Few-layer graphene and graphene nanoplatelets have shown variable results depending on lateral size, thickness, and dose.
At high doses, graphene materials can cause granuloma formation — small clusters of immune cells that form around foreign particles in lung tissue. This is a response seen with many insoluble particulates, not unique to graphene. At lower doses, the inflammatory response is typically less severe and may resolve over time.
The fiber paradigm concern. One of the more significant concerns in graphene toxicology is whether large, thin graphene platelets might behave like pathogenic fibers — similar to asbestos — in lung tissue. The “fiber paradigm” holds that materials with high aspect ratios (long and thin) can cause persistent inflammation because macrophages (immune cells) cannot fully engulf them, leading to frustrated phagocytosis and chronic inflammation.
Some graphene nanoplatelets have lateral dimensions of several micrometers but are only nanometers thick, giving them aspect ratios that could potentially trigger this response. Research on this question is ongoing, and results are mixed — some studies have observed frustrated phagocytosis with large graphene platelets, while others have not, depending on the specific material characteristics and experimental conditions.
This is an area where the precautionary principle applies. Until the fiber paradigm question is resolved for specific graphene material types, treating airborne graphene as a potentially hazardous dust is warranted.
Exposure limits. As of 2026, no country has established a specific occupational exposure limit (OEL) for graphene. In the absence of graphene-specific limits, regulatory guidance generally recommends applying precautionary limits for nanomaterials — typically the same controls used for other insoluble nanoscale particles. NIOSH’s recommended exposure limit for carbon nanotubes and nanofibers (1 μg/m³ as a time-weighted average) is sometimes used as a reference point for graphene, though this has not been formally established.
Skin and Dermal Exposure
Skin exposure to graphene is generally considered a lower-priority concern than inhalation, but it is not negligible, particularly for workers handling graphene dispersions and inks.
Pristine graphene is hydrophobic and does not easily penetrate intact skin. Graphene oxide, which is hydrophilic and can carry surface charges, has shown some potential for skin irritation in concentrated formulations. Studies on dermal penetration have produced variable results, with most suggesting that graphene-family materials do not readily penetrate intact skin barriers but may penetrate damaged or compromised skin.
For practical purposes, standard chemical handling practices — gloves, lab coats, minimizing direct skin contact with concentrated graphene dispersions — are appropriate and sufficient based on current evidence. This is consistent with the handling protocols for other nanomaterial dispersions.
Ingestion and Oral Exposure
For consumers using products containing graphene (composites, coatings, sporting goods), ingestion is a potential exposure route, though typically at very low doses.
Oral toxicity studies in animals have generally shown low acute toxicity for graphene-family materials. Graphene’s hydrophobicity limits its absorption through the gastrointestinal tract, and most ingested material is excreted. Graphene oxide, being more water-dispersible, shows somewhat higher bioavailability but has still demonstrated relatively low oral toxicity in animal studies at environmentally relevant doses.
The caveat is that long-term, low-dose oral exposure data is limited. For products where graphene is locked into a polymer matrix (composites, coatings), the risk of consumer exposure is minimal — the graphene is not free to be inhaled or ingested during normal product use. Risk is primarily during manufacturing, machining, sanding, or end-of-life processing of graphene-containing products.
Environmental Fate
What happens to graphene when it enters the environment — through industrial discharge, product wear, or end-of-life disposal — is a question with limited but growing research.
Graphene oxide is water-dispersible and can persist in aquatic environments. Studies on aquatic organisms (fish, algae, water fleas) have shown variable toxicity depending on concentration, GO characteristics, and the specific organism. At environmentally relevant concentrations (likely in the low μg/L range for current production volumes), acute toxicity effects are generally not observed, but chronic effects and ecosystem-level impacts are poorly understood.
Pristine graphene, being hydrophobic, tends to aggregate and settle out of aquatic environments. Its environmental persistence and degradation pathways are not well characterized. Some evidence suggests that microbial degradation of graphene oxide occurs, but degradation rates and completeness vary.
The environmental toxicology of graphene is substantially less mature than the occupational health research. As production volumes increase, this gap becomes more significant.
What Responsible Handling Looks Like
Based on the current evidence — acknowledging its limitations — the following precautionary approach is appropriate for organizations working with graphene-family materials:
Engineering controls. Handle dry graphene powders in well-ventilated environments, preferably with local exhaust ventilation at the point of generation. Enclosed production systems are preferable where feasible. Use HEPA filtration for air handling systems in graphene processing areas.
Personal protective equipment. N95 or higher respiratory protection when handling dry graphene powders or when engineering controls may be insufficient. Nitrile or latex gloves for handling graphene dispersions. Safety glasses or goggles during powder handling. Standard lab coat or protective clothing.
Monitoring. Airborne particulate monitoring in production and handling areas. Personal exposure monitoring for workers with regular graphene contact. While graphene-specific analytical methods are still developing, total particulate and nanoparticle counting methods provide useful exposure assessment.
Documentation. Safety data sheets (SDS) for all graphene materials used. Exposure records for workers. Incident documentation and reporting.
Training. Worker awareness of nanomaterial handling practices. Understanding that different graphene-family materials may have different risk profiles. Proper use and maintenance of PPE.
The Bottom Line
The graphene safety picture is incomplete. The available evidence suggests that graphene-family materials are not acutely toxic at typical occupational exposures, but that chronic inhalation exposure at elevated concentrations can cause pulmonary inflammation. The fiber paradigm question — whether large graphene platelets can cause asbestos-like pathology — remains open and warrants precaution.
The responsible position is to treat graphene as a potentially hazardous nanomaterial and apply appropriate controls until the science provides clearer guidance. This is not an alarmist position — it is exactly how the occupational health community approaches any new industrial material with incomplete toxicology data. The controls required (ventilation, respiratory protection, good housekeeping) are straightforward and not prohibitively expensive.
What the industry should avoid is either dismissing safety concerns because “graphene is just carbon” (it is a nanomaterial with unique biological interactions) or overstating risks in ways that impede legitimate commercial development. The evidence supports cautious, well-managed industrial use — which is what competent producers are already practicing.
This article is part of our Standards & Safety series. For regulatory context, see our upcoming article on REACH, TSCA, and graphene nanomaterial regulations. For quality and characterization guidance, see Buying Graphene: A Procurement Guide.